ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

WHO2023EN

Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

Zusammenfassung

Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders Design and layout: Green Ink Publishing Services Ltd Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders This publication is the update of the documents published in 2010 entitled “mhGAP intervention guide for mental,

Kerninformationen

slation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/). ...
ce to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published ...
ist of essential medicines (EML) 112 5. Monitoring and evaluating the impact of the guideline 113 6. Updating the evidence 114 References 115 Annex 1. Contributors to the guideline 130 Annex 2. Managing declarations of interest and conflicts of interest 145 v Acknowledgements This World ...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien